Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelos Andreakos

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Expert Opinion on Biological Therapy|June 5, 2003
Targeting cytokines in autoimmunity: new approaches, new promiseEvangelos Andreakos
Seminars in Immunology|January 25, 2024
Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyondEvangelos Andreakos,
EMBO Molecular Medicine|April 26, 2020
COVID-19: lambda interferon against viral load and hyperinflammationEvangelos Andreakos, Sotirios Tsiodras
Journal of Autoimmunity|September 5, 2019
Lambda interferons in immunity and autoimmunityStelios Vlachiotis, Evangelos Andreakos
Methods in Molecular Biology (Clifton, N.J.)|September 17, 2013
Therapeutic human monoclonal antibodies in inflammatory diseasesSotirios Kotsovilis, Evangelos Andreakos
Biochemical Pharmacology|March 27, 2019
The many facets of macrophages in rheumatoid arthritisEleni Siouti, Evangelos Andreakos
Journal of Leukocyte Biology|July 11, 2015
Neutrophils in viral infections: Current concepts and caveatsIoanna E Galani, Evangelos Andreakos
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 6, 2004
Activation of signalling pathways during hepatocyte isolation: relevance to toxicology in vitroAlan J Paine, Evangelos Andreakos
Science Translational Medicine|October 3, 2014
IL-25: the missing link between allergy, viral infection, and asthma?Evangelos Andreakos, Nikolaos G Papadopoulos
Seminars in Immunology|November 24, 2021
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunitiesIoanna-Evdokia Galani, Evangelos Andreakos
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Expert Opinion on Biological Therapy|June 5, 2003
Targeting cytokines in autoimmunity: new approaches, new promiseEvangelos Andreakos
Seminars in Immunology|January 25, 2024
Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyondEvangelos Andreakos,
EMBO Molecular Medicine|April 26, 2020
COVID-19: lambda interferon against viral load and hyperinflammationEvangelos Andreakos, Sotirios Tsiodras
Journal of Autoimmunity|September 5, 2019
Lambda interferons in immunity and autoimmunityStelios Vlachiotis, Evangelos Andreakos
Methods in Molecular Biology (Clifton, N.J.)|September 17, 2013
Therapeutic human monoclonal antibodies in inflammatory diseasesSotirios Kotsovilis, Evangelos Andreakos
Biochemical Pharmacology|March 27, 2019
The many facets of macrophages in rheumatoid arthritisEleni Siouti, Evangelos Andreakos
Journal of Leukocyte Biology|July 11, 2015
Neutrophils in viral infections: Current concepts and caveatsIoanna E Galani, Evangelos Andreakos
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 6, 2004
Activation of signalling pathways during hepatocyte isolation: relevance to toxicology in vitroAlan J Paine, Evangelos Andreakos
Science Translational Medicine|October 3, 2014
IL-25: the missing link between allergy, viral infection, and asthma?Evangelos Andreakos, Nikolaos G Papadopoulos
Seminars in Immunology|November 24, 2021
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunitiesIoanna-Evdokia Galani, Evangelos Andreakos
Pageof 10